CALOGERO, Raffaele Adolfo
CALOGERO, Raffaele Adolfo
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells
2018-01-01 Olivero, Martina; Erriquez, Jessica; Arigoni, Maddalena; Capellero, Sonia; D'Ambrosio, Concetta; Mittica, Gloria; Borella, Fulvio; Katsaros, Dionyssios; Privitera, Silvana; Berrino, Enrico; Venesio, Tiziana; Valabrega, Giorgio; Calogero, Raffaele; Renzo, Maria Flavia Di
Assays of conventional chemotherapeutics and targeted drugs for ovarian cancer using patient derived models
2019-01-01 Concetta D’Ambrosio, Jessica Erriquez, Maddalena Arigoni, Sonia Capellero, Gloria Mittica, Eleonora Ghisoni, Fulvio Borella, Dionyssios Katsaros, Silvana Privitera, Marisa Ribotta, Elena Maldi, Giovanna Di Nardo, Enrico Berrino, Tiziana Venesio, Riccardo Ponzone, Marco Vaira, Douglas Hall, Mercedes Jimenez-Linan, Anna L. Paterson, Giorgio Valabrega, Raffaele A. Calogero, James D. Brenton, Maria Flavia Di Renzo and Martina Olivero
Cancer Stem Cell based adjuvant for oncoantingen-driven vaccination
2011-01-01 F. Cordero; C. Fornari; F. Cavallo; S. Lanzardo; L. Conti; D. Manini; M. Arigoni; G. Balbo; R.A. Calogero
CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin
2010-01-01 Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF
Differential expression of DNA repair machinery genes in normal bronchial tissue and non-small cell lung cancer (NSCLC)
2008-01-01 G. Selvaggi; S. Saviozzi; P. Ceppi; M. Volante; M. Lo Iacono; S. Novello; M. Longo; R. Calogero; M. Papotti; G. V. Scagliotti
Early gene expression profiling through a macro-arrayapproach on non-apoptotic human monocytes fed withhemozoin (malarial pigment)
2010-01-01 M. Prato; D. Ulliers; V. Gallo; E. Schwarzer; O.B. Akide-Ndunge; G. Mandili; A. Khadjavi; S. Saviozzi; R.A. Calogero; P. Arese; G. Giribaldi
Enhanced Proinflammatory Response and Missing Apoptosis in Hemozoin-Fed Human Monocytes: a HSP-27-Mediated Anomaly in Falciparum Malaria
2010-01-01 Prato, M; Ulliers, D; Gallo, V; Schwarzer, E; Akide-Ndunge, O B; Mandili, G; Saviozzi, S; Calogero, R A; Arese, P; Giribaldi, G
Gene Ontology rewritten for computing gene functional similarity
2010-01-01 Visconti A.; Cordero F.; Botta M.; Calogero R.A
How steady states analysis helps cancer therapies
2013-01-01 Fornari Chiara; Cordero Francesca; Beccuti Marci; Balbo Gianfranco; Calogero Raffaele
Identification of Teneurin 4 as a novel cancer-stem cell associated antigen and potential biomarker.
2021-01-01 Peppino G., Barutello G., Ruiu R., Arigoni M., Riccardo F., Conti L., Calogero R.A., Quaglino E.
Improving biomarker discovering for chemosensitivity prediction using an integrated approach
2012-01-01 Francesca Cordero; Alessia Visconti; Raffaele A Calogero
Mathematical approach to predict the drug effects on cancer stem cell models
2011-01-01 Chiara Fornari; Francesca Cordero; Daniele Manini; Gianfranco Balbo; Raffaele Calogero
Modeling biological systems considering the uncertainty associated with model parameters
2016-01-01 Marco Beccuti, Niccolò Totis, Laura Follia, Raffaele Calogero, Francesca Cordero, Gianfranco Balbo
Multi-level model for the investigation of oncoantigen-driven vaccination effect
2012-01-01 C. FORNARI; F. Cordero; M. Beccuti; S. Lanzardo; L. Conti; F. Cavallo; G. Balbo; R.A. Calogero
Multiple sclerosis disease: A computational approach for investigating its drug interactions
2020-01-01 Pernice S.; Beccuti M.; Romano G.; Pennisi M.; Maglione A.; Cutrupi S.; Pappalardo F.; Capra L.; Franceschinis G.; De Pierro M.; Balbo G.; Cordero F.; Calogero R.
P38MAPK highlights the dark side of Met/HGF pathway in ovarian cancer
2007-01-01 Lorenzato A; Coltella N; Olivero M; Martino C; Dettori D; Cossu C; Calogero R; Di Renzo MF
The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C
2011-01-01 Lorenzato A; Martino C; Olivero M; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Di Renzo MF
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors
2011-01-01 Dani N; Olivero M; Mareschi K; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
The multi-level view to investigate the cancer progression
2013-01-01 Francesca Cordero; Chiara Fornari; Marco Beccuti; Gianfranco Balbo; raffaele calogero
Urine microRNA profiling in bladder cancer by next-generation sequencing
2017-01-01 Pardini, Barbara; Cordero, Francesca; Naccarati, Alessio; Ferrero, Giulio; Viberti, Clara; Oderda, Marco; Arigoni, Maddalena; Calogero, Raffaele; Sacerdote, Carlotta; Gontero, Paolo; Vineis, Paolo; Matullo, Giuseppe
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells | 2018 | Olivero, Martina; Erriquez, Jessica; Arigoni, Maddalena; Capellero, Sonia; D'Ambrosio, Concetta; Mittica, Gloria; Borella, Fulvio; Katsaros, Dionyssios; Privitera, Silvana; Berrino, Enrico; Venesio, Tiziana; Valabrega, Giorgio; Calogero, Raffaele; Renzo, Maria Flavia Di | |
| Assays of conventional chemotherapeutics and targeted drugs for ovarian cancer using patient derived models | 2019 | Concetta D’Ambrosio, Jessica Erriquez, Maddalena Arigoni, Sonia Capellero, Gloria Mittica, Eleonora Ghisoni, Fulvio Borella, Dionyssios Katsaros, Silvana Privitera, Marisa Ribotta, Elena Maldi, Giovanna Di Nardo, Enrico Berrino, Tiziana Venesio, Riccardo Ponzone, Marco Vaira, Douglas Hall, Mercedes Jimenez-Linan, Anna L. Paterson, Giorgio Valabrega, Raffaele A. Calogero, James D. Brenton, Maria Flavia Di Renzo and Martina Olivero | |
| Cancer Stem Cell based adjuvant for oncoantingen-driven vaccination | 2011 | F. Cordero; C. Fornari; F. Cavallo; S. Lanzardo; L. Conti; D. Manini; M. Arigoni; G. Balbo; R.A. Calogero | |
| CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin | 2010 | Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF | |
| Differential expression of DNA repair machinery genes in normal bronchial tissue and non-small cell lung cancer (NSCLC) | 2008 | G. Selvaggi; S. Saviozzi; P. Ceppi; M. Volante; M. Lo Iacono; S. Novello; M. Longo; R. Calogero; M. Papotti; G. V. Scagliotti | |
| Early gene expression profiling through a macro-arrayapproach on non-apoptotic human monocytes fed withhemozoin (malarial pigment) | 2010 | M. Prato; D. Ulliers; V. Gallo; E. Schwarzer; O.B. Akide-Ndunge; G. Mandili; A. Khadjavi; S. Saviozzi; R.A. Calogero; P. Arese; G. Giribaldi | |
| Enhanced Proinflammatory Response and Missing Apoptosis in Hemozoin-Fed Human Monocytes: a HSP-27-Mediated Anomaly in Falciparum Malaria | 2010 | Prato, M; Ulliers, D; Gallo, V; Schwarzer, E; Akide-Ndunge, O B; Mandili, G; Saviozzi, S; Calogero, R A; Arese, P; Giribaldi, G | |
| Gene Ontology rewritten for computing gene functional similarity | 2010 | Visconti A.; Cordero F.; Botta M.; Calogero R.A | |
| How steady states analysis helps cancer therapies | 2013 | Fornari Chiara; Cordero Francesca; Beccuti Marci; Balbo Gianfranco; Calogero Raffaele | |
| Identification of Teneurin 4 as a novel cancer-stem cell associated antigen and potential biomarker. | 2021 | Peppino G., Barutello G., Ruiu R., Arigoni M., Riccardo F., Conti L., Calogero R.A., Quaglino E. | |
| Improving biomarker discovering for chemosensitivity prediction using an integrated approach | 2012 | Francesca Cordero; Alessia Visconti; Raffaele A Calogero | |
| Mathematical approach to predict the drug effects on cancer stem cell models | 2011 | Chiara Fornari; Francesca Cordero; Daniele Manini; Gianfranco Balbo; Raffaele Calogero | |
| Modeling biological systems considering the uncertainty associated with model parameters | 2016 | Marco Beccuti, Niccolò Totis, Laura Follia, Raffaele Calogero, Francesca Cordero, Gianfranco Balbo | |
| Multi-level model for the investigation of oncoantigen-driven vaccination effect | 2012 | C. FORNARI; F. Cordero; M. Beccuti; S. Lanzardo; L. Conti; F. Cavallo; G. Balbo; R.A. Calogero | |
| Multiple sclerosis disease: A computational approach for investigating its drug interactions | 2020 | Pernice S.; Beccuti M.; Romano G.; Pennisi M.; Maglione A.; Cutrupi S.; Pappalardo F.; Capra L.; Franceschinis G.; De Pierro M.; Balbo G.; Cordero F.; Calogero R. | |
| P38MAPK highlights the dark side of Met/HGF pathway in ovarian cancer | 2007 | Lorenzato A; Coltella N; Olivero M; Martino C; Dettori D; Cossu C; Calogero R; Di Renzo MF | |
| The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C | 2011 | Lorenzato A; Martino C; Olivero M; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Di Renzo MF | |
| The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors | 2011 | Dani N; Olivero M; Mareschi K; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF | |
| The multi-level view to investigate the cancer progression | 2013 | Francesca Cordero; Chiara Fornari; Marco Beccuti; Gianfranco Balbo; raffaele calogero | |
| Urine microRNA profiling in bladder cancer by next-generation sequencing | 2017 | Pardini, Barbara; Cordero, Francesca; Naccarati, Alessio; Ferrero, Giulio; Viberti, Clara; Oderda, Marco; Arigoni, Maddalena; Calogero, Raffaele; Sacerdote, Carlotta; Gontero, Paolo; Vineis, Paolo; Matullo, Giuseppe |